Biohaven Ltd’s recently made public that its Director CHILDS JOHN W acquired Company’s shares for reported $1.04 million on Dec 30 ’24. In the deal valued at $35.94 per share,29,000 shares were bought. As a result of this transaction, CHILDS JOHN W now holds 2,368,741 shares worth roughly $88.07 million.
Then, CHILDS JOHN W bought 21,052 shares, generating $999,970 in total proceeds. Upon buying the shares at $47.50, the Director now owns 21,052 shares.
Before that, Coric Vlad bought 21,052 shares. Biohaven Ltd shares valued at $999,970 were divested by the Chief Executive Officer at a price of $47.50 per share. As a result of the transaction, Coric Vlad now holds 861,942 shares, worth roughly $32.05 million.
Deutsche Bank initiated its Biohaven Ltd [BHVN] rating to a Buy in a research note published on February 11, 2025; the price target was $65. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid September with a ‘”a Buy”‘ rating. Bernstein began covering BHVN with “an Outperform” recommendation on September 04, 2024. Morgan Stanley started covering the stock on July 24, 2024. It rated BHVN as “an Overweight”.
Price Performance Review of BHVN
On Friday, Biohaven Ltd [NYSE:BHVN] saw its stock jump 1.75% to $37.18. Over the last five days, the stock has gained 0.73%. Biohaven Ltd shares have fallen nearly -0.46% since the year began. Nevertheless, the stocks have fallen -21.99% over the past one year. While a 52-week high of $62.21 was reached on 02/11/25, a 52-week low of $26.80 was recorded on 02/25/25. SMA at 50 days reached $38.20, while 200 days put it at $40.71.
Levels Of Support And Resistance For BHVN Stock
The 24-hour chart illustrates a support level at 35.76, which if violated will result in even more drops to 34.34. On the upside, there is a resistance level at 37.98. A further resistance level may holdings at 38.78. The Relative Strength Index (RSI) on the 14-day chart is 44.80, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.91, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 68.60%. Stochastics %K at 29.34% indicates the stock is a holding.
The most recent change occurred on February 16, 2024 when RBC Capital Mkts began covering the stock and recommended ‘”an Outperform”‘ rating along with a $62 price target.
